22.418 articles found

4-SUBSTITUTED 4, 6-DIALKOXY-CINNOLINE DERIVATIVES AS PHOSPODIESTERASE 10 INHIBITORS FOR THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL SYNDROMS

ARRINGTON Mark Phillip, LIU Ruiping, CONTICELLO Richard D., GAUSS Carla Maria, HOPPER Allen, NGUYEN Truc Minh, TEHIM Ashok.

· 2005-09-02

4-SUBSTITUTED 4,6-DIALKOXY-CINNOLINE DERIVATIVES AS PHOSPODIESTERASE 10 INHIBITORS FOR THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL SYNDROMS

ARRINGTON Mark Phillip, LIU Ruiping, CONTICELLO Richard D., GAUSS Carla Maria, HOPPER Allen, NGUYEN Truc Minh, TEHIM Ashok.

· 2005-09-02

Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease--therapeutic potential.

Paschen W, Mengesdorf T.

Pharmacol Ther · 2005-09-02

DOI: 10.1016/j.pharmthera.2005.05.008PMID: 16140387

Efficient therapeutic gene expression in cultured rat hippocampal neurons mediated by human foamy virus vectors: a potential for the treatment of neurological diseases.

Liu W, He X, Cao Z, Sheng J, Liu H, Li Z, Li W.

Intervirology · 2005-09-01

DOI: 10.1159/000085102PMID: 15956801

Evaluation of acupuncture in the treatment of Parkinson's disease: a double-blind pilot study.

Cristian A, Katz M, Cutrone E, Walker RH.

Mov Disord · 2005-09-01

DOI: 10.1002/mds.20503PMID: 15884039

A disposable electrochemical sensor for the rapid determination of levodopa.

Bergamini MF, Santos AL, Stradiotto NR, Stradiotto NR, Zanoni MV.

J Pharm Biomed Anal · 2005-09-01

DOI: 10.1016/j.jpba.2005.03.014PMID: 15896939

An active transport system in the blood-brain barrier may reduce levodopa availability.

Hawkins RA, Mokashi A, Simpson IA.

Exp Neurol · 2005-09-01

DOI: 10.1016/j.expneurol.2005.04.008PMID: 15925365

Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.

Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA.

Mov Disord · 2005-09-01

DOI: 10.1002/mds.20563PMID: 15954135

High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.

Storch A, Trenkwalder C, Oehlwein C, Winkelmann J, Polzer U, Hundemer HP, Schwarz J.

Parkinsonism Relat Disord · 2005-09-01

DOI: 10.1016/j.parkreldis.2005.03.005PMID: 15993640

Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.

Chou KL, Hurtig HI, Jaggi JL, Baltuch GH, Pelchat RJ, Weintraub D.

Parkinsonism Relat Disord · 2005-09-01

DOI: 10.1016/j.parkreldis.2005.04.005PMID: 15994113

Hedonistic homeostatic dysregulation in Parkinson's disease and excess dopamine replacement therapy.

Grosset K, Grosset D.

Mov Disord · 2005-09-01

DOI: 10.1002/mds.20616PMID: 16037920

New therapeutic approaches to Parkinson's disease including neural transplants.

Kuan WL, Barker RA.

Neurorehabil Neural Repair · 2005-09-01

DOI: 10.1177/1545968305277219PMID: 16093408